This is a demo store. No orders will be fulfilled.
USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Life Sciences
Frost & Sullivan's expertise in Life Sciences research and consulting includes work in diversified strategic and operational areas
The life sciences industry is undergoing rapid change, dynamic discoveries and pressures driving business decisions and corporate growth. Business models are being forced to evolve as healthcare continues to shift from a treatment focus to points of wellness, prediction, personalization, and prevention.
Recognizing the interdependence of the payer, provider and pharmaceutical value chains, companies are re-inventing strategies in multitude ways: increased outsourcing, co-development and patient engagement are the new norms.
The Frost & Sullivan Global Life Sciences Program helps you better understand stakeholder dynamics as the healthcare system transitions from acute care into integrated care. Our research and insights help you make informed strategic decisions around how best to navigate this complex market.
We can support needs from syndicated research to projects ranging from proprietary strategic engagements and market research, marketing solutions, and whitepapers, all leveraging the global reach of our firm to propel your business forward.
We believe a structured partnership that provides you transformational insights through online content as well as deeper interaction with our senior analyst team will help ensure greater relevancy of insights provided for your organization.
-
30 Mar 2019 | North America | Technology Research
Breakthroughs in Non-Alcoholic Steatohepatitis Management
Multiple Investigational New Drugs with high potential for better treatment outcomes progressing through critical stages of clinical development
Non-Alcoholic Steatohepatitis or NASH is a liver disorder that is characterized by the build-up of fat in liver in addition to inflammation and liver cell damage eventually progressing to cirrhosis. Currently lifestyle interventions are suggested for the treatment of NASH with no drugs having been approved for the condition. Multiple drugs are at ...
$4,950.00 -
28 Sep 2018 | North America | Technology Research
Gene Editing and Gene Therapy Breakthroughs to Propel Mainstream Disease Treatments
A new wave of gene therapies is set to revolutionize treatments over the next decade for inherited diseases which are either untreatable or which do not have a satisfactory treatment outcome at present
The drug approvals of Yescarta (axicabtagene ciloleucel), Luxturna (Voretigene neparvovec) and Kymriah (Tisagenlecleucel) have turned a leaf in the pharmaceutical chapter of gene therapy development. Currently, genetic disorders do not have satisfactory treatment outcomes. This is in part due to the inability of small molecule drugs and enzyme repl...
$4,950.00 -
29 Dec 2017 | North America | Technology Research
Innovations in Transdermal Drug Delivery
Microneedle Technologies Creating Novel Opportunities in Transdermal Drug Delivery Industry
With the healthcare industry moving toward patient convenience and comfort, pharmaceutical and medical device companies are continuously researching for the most effective, side effect free, convenient route of drug delivery. Transdermal drug delivery is a painless method of delivering drug formulation. Transdermal route of drug administration has ...
$4,950.00 -
01 Feb 2013 | North America | Economic and Databases
Decision Support Database - Burden Of Disease And Conditions
Burden of Disease or Conditions Decision Support Database provides information on exhaustive list of Measurements on Incidence, Prevalence and Mortality for different types of Communicable and Non Communicable Disease.
$1,500.00 -
16 Jun 2007 | Asia Pacific | Economic and Databases
Country Industry Forecast - Economic Analysis for the South Korean Healthcare Industry
Strong economic growth and increasing public healthcare expenditure has contributed to the growth of healthcare industry in South Korea. The Government is currently focusing on upgrading the healthcare centres, increase the number of healthcare facilities and training programs for doctors. These are expected to result in increased coverage of heal...
$450.00 -
07 Feb 2007 | Asia Pacific | Economic and Databases
Country Industry Forecast - Political and Policy Analysis for the South Korean Healthcare Industry
After the Asian economic crisis in 1997, the South Korean healthcare industry underwent a phase of overhauling with government initiatives such as the introduction of health insurance and others.These initiatives by the government were aimed at bringing down the costs and increase the competitiveness of the healthcare industry through series of hea...
$450.00
